Annual Retained Earnings
-$561.39 M
-$95.06 M-20.38%
December 31, 2024
Summary
- As of March 7, 2025, ALT annual retained earnings is -$561.39 million, with the most recent change of -$95.06 million (-20.38%) on December 31, 2024.
- During the last 3 years, ALT annual retained earnings has fallen by -$268.22 million (-91.49%).
- ALT annual retained earnings is now -202548.61% below its all-time high of $277.30 thousand, reached on December 31, 2005.
Performance
ALT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$561.39 M
-$23.18 M-4.31%
December 31, 2024
Summary
- As of March 7, 2025, ALT quarterly retained earnings is -$561.39 million, with the most recent change of -$23.18 million (-4.31%) on December 31, 2024.
- Over the past year, ALT quarterly retained earnings has dropped by -$95.06 million (-20.38%).
- ALT quarterly retained earnings is now -34444.18% below its all-time high of $1.63 million, reached on March 31, 2007.
Performance
ALT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ALT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.4% | -20.4% |
| 3 y3 years | -91.5% | -91.5% |
| 5 y5 years | -308.6% | -308.6% |
ALT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.5% | at low | -91.5% | at low |
| 5 y | 5-year | -308.6% | at low | -308.6% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Altimmune Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$561.39 M(+20.4%) | -$561.39 M(+4.3%) |
| Sep 2024 | - | -$538.21 M(+4.4%) |
| Jun 2024 | - | -$515.37 M(+5.0%) |
| Mar 2024 | - | -$490.73 M(+5.2%) |
| Dec 2023 | -$466.33 M(+23.4%) | -$466.33 M(+7.3%) |
| Sep 2023 | - | -$434.69 M(+5.0%) |
| Jun 2023 | - | -$414.02 M(+4.0%) |
| Mar 2023 | - | -$397.96 M(+5.3%) |
| Dec 2022 | -$377.88 M(+28.9%) | -$377.88 M(+6.1%) |
| Sep 2022 | - | -$356.22 M(+7.1%) |
| Jun 2022 | - | -$332.71 M(+6.4%) |
| Mar 2022 | - | -$312.60 M(+6.6%) |
| Dec 2021 | -$293.17 M(+57.3%) | -$293.17 M(+8.9%) |
| Sep 2021 | - | -$269.28 M(+14.2%) |
| Jun 2021 | - | -$235.77 M(+11.8%) |
| Mar 2021 | - | -$210.94 M(+13.2%) |
| Dec 2020 | -$186.42 M(+35.7%) | -$186.42 M(+6.0%) |
| Sep 2020 | - | -$175.80 M(+11.2%) |
| Jun 2020 | - | -$158.03 M(+11.9%) |
| Mar 2020 | - | -$141.26 M(+2.8%) |
| Dec 2019 | -$137.38 M(+17.6%) | -$137.38 M(+3.1%) |
| Sep 2019 | - | -$133.28 M(+8.9%) |
| Jun 2019 | - | -$122.34 M(+2.8%) |
| Mar 2019 | - | -$118.95 M(+1.8%) |
| Dec 2018 | -$116.86 M(+50.4%) | -$116.86 M(+26.5%) |
| Sep 2018 | - | -$92.35 M(+2.6%) |
| Jun 2018 | - | -$90.00 M(+11.3%) |
| Mar 2018 | - | -$80.86 M(+4.1%) |
| Dec 2017 | -$77.68 M(+148.5%) | -$77.68 M(+12.8%) |
| Sep 2017 | - | -$68.85 M(+76.8%) |
| Jun 2017 | - | -$38.95 M(+21.5%) |
| Mar 2017 | - | -$32.07 M(+2.6%) |
| Dec 2016 | -$31.26 M(-86.0%) | -$31.26 M(-71.0%) |
| Sep 2016 | - | -$107.67 M(-50.4%) |
| Jun 2016 | - | -$216.91 M(-3.6%) |
| Mar 2016 | - | -$224.95 M(+0.5%) |
| Dec 2015 | -$223.72 M | -$223.72 M(+0.6%) |
| Sep 2015 | - | -$222.49 M(+0.6%) |
| Jun 2015 | - | -$221.16 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -$218.82 M(-0.7%) |
| Dec 2014 | -$220.28 M(+4.7%) | -$220.28 M(+1.2%) |
| Sep 2014 | - | -$217.65 M(+2.2%) |
| Jun 2014 | - | -$213.03 M(+0.2%) |
| Mar 2014 | - | -$212.59 M(+1.1%) |
| Dec 2013 | -$210.33 M(+5.9%) | -$210.33 M(+2.1%) |
| Sep 2013 | - | -$205.90 M(+2.0%) |
| Jun 2013 | - | -$201.96 M(+0.6%) |
| Mar 2013 | - | -$200.72 M(+1.1%) |
| Dec 2012 | -$198.61 M(+2.5%) | -$198.61 M(+0.6%) |
| Sep 2012 | - | -$197.34 M(+0.1%) |
| Jun 2012 | - | -$197.13 M(+0.4%) |
| Mar 2012 | - | -$196.37 M(+1.4%) |
| Dec 2011 | -$193.69 M(+2.0%) | -$193.69 M(-0.4%) |
| Sep 2011 | - | -$194.44 M(+0.0%) |
| Jun 2011 | - | -$194.41 M(+1.3%) |
| Mar 2011 | - | -$191.97 M(+1.1%) |
| Dec 2010 | -$189.89 M(+22.5%) | -$189.89 M(+8.5%) |
| Sep 2010 | - | -$174.98 M(+2.5%) |
| Jun 2010 | - | -$170.65 M(+3.9%) |
| Mar 2010 | - | -$164.25 M(+5.9%) |
| Dec 2009 | -$155.04 M(+25.2%) | -$155.04 M(+2.9%) |
| Sep 2009 | - | -$150.64 M(+10.2%) |
| Jun 2009 | - | -$136.68 M(+5.3%) |
| Mar 2009 | - | -$129.83 M(+4.9%) |
| Dec 2008 | -$123.82 M(+41.7%) | -$123.82 M(+4.4%) |
| Sep 2008 | - | -$118.62 M(+3.8%) |
| Jun 2008 | - | -$114.27 M(+23.6%) |
| Mar 2008 | - | -$92.42 M(+5.7%) |
| Dec 2007 | -$87.40 M(+25.1%) | -$87.40 M(+6.2%) |
| Sep 2007 | - | -$82.30 M(-5135.1%) |
| Mar 2007 | - | $1.63 M(-102.3%) |
| Dec 2006 | -$69.85 M(<-9900.0%) | -$69.85 M(-6647.8%) |
| Sep 2006 | - | $1.07 M(+39.3%) |
| Jun 2006 | - | $765.60 K(+58.9%) |
| Mar 2006 | - | $481.70 K(+73.7%) |
| Dec 2005 | $277.30 K | $277.30 K(+92.6%) |
| Sep 2005 | - | $144.00 K(-5860.0%) |
| Jun 2005 | - | -$2500.00 |
FAQ
- What is Altimmune annual retained earnings?
- What is the all time high annual retained earnings for Altimmune?
- What is Altimmune annual retained earnings year-on-year change?
- What is Altimmune quarterly retained earnings?
- What is the all time high quarterly retained earnings for Altimmune?
- What is Altimmune quarterly retained earnings year-on-year change?
What is Altimmune annual retained earnings?
The current annual retained earnings of ALT is -$561.39 M
What is the all time high annual retained earnings for Altimmune?
Altimmune all-time high annual retained earnings is $277.30 K
What is Altimmune annual retained earnings year-on-year change?
Over the past year, ALT annual retained earnings has changed by -$95.06 M (-20.38%)
What is Altimmune quarterly retained earnings?
The current quarterly retained earnings of ALT is -$561.39 M
What is the all time high quarterly retained earnings for Altimmune?
Altimmune all-time high quarterly retained earnings is $1.63 M
What is Altimmune quarterly retained earnings year-on-year change?
Over the past year, ALT quarterly retained earnings has changed by -$95.06 M (-20.38%)